D V. Pokhabov

Krasnoyarsk, KYA, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis

Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 08, 2025

Modern and promising therapies for postherpetic neuralgia

Modern and promising therapies for postherpetic neuralgia

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: May 12, 2025

Art and creativity in Parkinson's disease: the mysterious effects of dopamine

Art and creativity in Parkinson's disease: the mysterious effects of dopamine

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: May 12, 2025

Tremor-dominant form of Parkinson's disease

Tremor-dominant form of Parkinson's disease

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 27, 2024

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 27, 2024

Postural stability and walking in Parkinson's disease

Postural stability and walking in Parkinson's disease

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: November 23, 2023

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 10, 2023

Analysis of GBA mutations in patients with Parkinson's disease in the Krasnoyarsk region

Analysis of GBA mutations in patients with Parkinson's disease in the Krasnoyarsk region

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 21, 2023

Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)

Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: November 28, 2022

Dynamics of cognitive impairments during L-dopa therapy in Parkinson's disease

Dynamics of cognitive impairments during L-dopa therapy in Parkinson's disease

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 30, 2021

A novel approach to differential diagnosis of Parkinson's disease and essential tremor

A novel approach to differential diagnosis of Parkinson's disease and essential tremor

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: January 18, 2021

Possibilities of retention of work capacity in patients with Parkinson's disease

Possibilities of retention of work capacity in patients with Parkinson's disease

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: October 23, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026